DE602005024320D1 - Bakterizidie-serumtest für n. meningitidis spezifische antiseren - Google Patents
Bakterizidie-serumtest für n. meningitidis spezifische antiserenInfo
- Publication number
- DE602005024320D1 DE602005024320D1 DE602005024320T DE602005024320T DE602005024320D1 DE 602005024320 D1 DE602005024320 D1 DE 602005024320D1 DE 602005024320 T DE602005024320 T DE 602005024320T DE 602005024320 T DE602005024320 T DE 602005024320T DE 602005024320 D1 DE602005024320 D1 DE 602005024320D1
- Authority
- DE
- Germany
- Prior art keywords
- meningitidis
- sba
- bactericidia
- antiser
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/22—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2005/009566 WO2007028408A1 (en) | 2005-09-05 | 2005-09-05 | Serum bactericidal assay for n. meningitidis specific antisera |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005024320D1 true DE602005024320D1 (de) | 2010-12-02 |
Family
ID=36090742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005024320T Active DE602005024320D1 (de) | 2005-09-05 | 2005-09-05 | Bakterizidie-serumtest für n. meningitidis spezifische antiseren |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8679770B2 (de) |
| EP (4) | EP2208999B1 (de) |
| JP (1) | JP5047969B2 (de) |
| AT (1) | ATE485516T1 (de) |
| CA (1) | CA2621578C (de) |
| DE (1) | DE602005024320D1 (de) |
| ES (3) | ES2407683T3 (de) |
| WO (1) | WO2007028408A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| PE20110072A1 (es) * | 2005-06-27 | 2011-02-04 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| US7955817B2 (en) | 2005-09-02 | 2011-06-07 | Glaxosmithkline Biologicals S.A. | Vaccine protection assay |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| CA2746942A1 (en) * | 2008-12-22 | 2010-07-01 | Children's Hospital & Research Center At Oakland | Ex-vivo passive protection bacteremia assay |
| US20110269149A1 (en) * | 2009-01-15 | 2011-11-03 | Tomomitsu Ozeki | Method for quantification of body internal concentration of protein-based drug |
| WO2012025873A2 (en) | 2010-08-23 | 2012-03-01 | Wyeth Llc | STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS |
| JP5976652B2 (ja) | 2010-09-10 | 2016-08-24 | ワイス・エルエルシー | 髄膜炎菌ｏｒｆ２０８６抗原の非脂質化変異体 |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| EP3485906A1 (de) | 2012-03-09 | 2019-05-22 | Pfizer Inc | Neisseria meningitidis-zusammensetzungen und verfahren dafür |
| CA2903716C (en) | 2013-03-08 | 2019-04-09 | Pfizer Inc. | Immunogenic fusion polypeptides |
| KR20180099912A (ko) | 2013-09-08 | 2018-09-05 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| WO2015128480A1 (en) | 2014-02-28 | 2015-09-03 | Novartis Ag | Modified meningococcal fhbp polypeptides |
| US10888611B2 (en) | 2015-02-19 | 2021-01-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| AU2017321863A1 (en) | 2016-09-02 | 2019-04-11 | Sanofi Pasteur, Inc. | Neisseria meningitidis vaccine |
| SG10202111092UA (en) | 2017-01-31 | 2021-11-29 | Pfizer | Neisseria meningitidis compositions and methods thereof |
| EP3607967A1 (de) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modifizierte meningokokken fhbp polypeptide |
| CN110903388B (zh) * | 2019-12-03 | 2024-01-02 | 兰州生物制品研究所有限责任公司 | 一种将脑膜炎球菌抗血清去交叉反应的方法 |
| GB202013262D0 (en) | 2020-08-25 | 2020-10-07 | Glaxosmithkline Biologicals Sa | Vaccine Composition |
| GB202208089D0 (en) | 2022-06-01 | 2022-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| GB202208093D0 (en) | 2022-06-01 | 2022-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69941574D1 (de) * | 1998-08-19 | 2009-12-03 | Baxter Healthcare Sa | Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| US20060034854A1 (en) | 2002-08-02 | 2006-02-16 | Berthet Francois-Xavier J | Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| EP1624888B1 (de) | 2003-05-07 | 2016-10-12 | Sanofi Pasteur, Inc. | Multivalente derivatisierte meningococcale polysaccharid-proteinkonjugate und entsprechende vakzine |
| US7955817B2 (en) | 2005-09-02 | 2011-06-07 | Glaxosmithkline Biologicals S.A. | Vaccine protection assay |
-
2005
- 2005-09-05 DE DE602005024320T patent/DE602005024320D1/de active Active
- 2005-09-05 EP EP10160317.3A patent/EP2208999B1/de active Active
- 2005-09-05 EP EP05786272A patent/EP1922546B1/de active Active
- 2005-09-05 ES ES10179015T patent/ES2407683T3/es active Active
- 2005-09-05 CA CA2621578A patent/CA2621578C/en not_active Expired - Fee Related
- 2005-09-05 EP EP10179015A patent/EP2336777B1/de active Active
- 2005-09-05 WO PCT/EP2005/009566 patent/WO2007028408A1/en active Application Filing
- 2005-09-05 EP EP10179009A patent/EP2333549A3/de not_active Withdrawn
- 2005-09-05 ES ES05786272T patent/ES2353516T3/es active Active
- 2005-09-05 JP JP2008528349A patent/JP5047969B2/ja not_active Expired - Fee Related
- 2005-09-05 US US12/065,682 patent/US8679770B2/en not_active Expired - Fee Related
- 2005-09-05 AT AT05786272T patent/ATE485516T1/de not_active IP Right Cessation
- 2005-09-05 ES ES10160317.3T patent/ES2522521T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20080220457A1 (en) | 2008-09-11 |
| US8679770B2 (en) | 2014-03-25 |
| ES2407683T3 (es) | 2013-06-13 |
| EP2336777A1 (de) | 2011-06-22 |
| EP2208999A3 (de) | 2011-09-21 |
| CA2621578C (en) | 2014-07-22 |
| ES2353516T3 (es) | 2011-03-02 |
| EP2208999B1 (de) | 2014-08-27 |
| EP2208999A2 (de) | 2010-07-21 |
| CA2621578A1 (en) | 2007-03-15 |
| WO2007028408A1 (en) | 2007-03-15 |
| EP2336777B1 (de) | 2013-04-03 |
| EP2333549A3 (de) | 2011-11-02 |
| JP5047969B2 (ja) | 2012-10-10 |
| EP2333549A2 (de) | 2011-06-15 |
| ES2522521T3 (es) | 2014-11-14 |
| JP2009507213A (ja) | 2009-02-19 |
| ATE485516T1 (de) | 2010-11-15 |
| EP1922546B1 (de) | 2010-10-20 |
| EP1922546A1 (de) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005024320D1 (de) | Bakterizidie-serumtest für n. meningitidis spezifische antiseren | |
| ATE532063T1 (de) | Elektrochemischer biosensor | |
| NO20076656L (no) | Forbedrede immunoassay metoder | |
| CN105102629A (zh) | 用于检测病原体的快速方法 | |
| TW200641352A (en) | Oxidizable species as an internal reference in control solutions for biosensors | |
| WO2006026020A3 (en) | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin | |
| WO2006131697A3 (en) | Test system | |
| TW200720441A (en) | New labelling strategies for the sensitive detection of analytes | |
| ATE535612T1 (de) | Toxizitätsscreeningverfahren | |
| WO2008007359A3 (en) | Rapid diagnostic devices based on molecular imprinted polymers | |
| MY162697A (en) | Methods, devices and kits for detecting or monitoring acute kidney injury | |
| DE60228557D1 (de) | Candida-nachweis | |
| SE0400191D0 (sv) | A test kit for detecting periodontal disease | |
| CY1112423T1 (el) | Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης | |
| ATE469351T1 (de) | Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c | |
| HK1094589A1 (de) | ||
| WO2008124091A3 (en) | Compositions and methods of detection | |
| SG170051A1 (en) | T cell assays | |
| FR2894675B1 (fr) | Distinction des meningites bacteriennes et virales | |
| WO2007022086A3 (en) | Antibodies and methods for predicting dental caries | |
| WO2009023331A3 (en) | Antibodies and improved test sample handling methods for use in assays for myeloperoxidase | |
| DE602005024254D1 (de) | ||
| Ohya et al. | Varying hemin concentrations affect Porphyromonas gingivalis strains differently | |
| WO2007060647A3 (en) | A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels | |
| DE602005010548D1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms |